134 related articles for article (PubMed ID: 38626049)
1. Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis.
Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Ateudjieu J; Kouanfack C; Dzudie A; Thienemann F; Tendongfor N; Nsagha DS; Choukem SP
PLOS Glob Public Health; 2024; 4(4):e0003042. PubMed ID: 38626049
[TBL] [Abstract][Full Text] [Related]
2. The effect of the Universal Test and Treat policy uptake on CD4 count testing and incidence of opportunistic infections among people living with HIV infection in Cameroon: a retrospective analysis of routine data.
Bekolo CE; Ndeso SA; Gougue CP; Moifo LL; Mangala N; Tchendjou P; Mboh E; Ateudjieu J; Tendongfor N; Nsagha DS; Halle-Ekane GE; Choukem SP
Dialogues Health; 2023 Dec; 2():100120. PubMed ID: 38515498
[TBL] [Abstract][Full Text] [Related]
3. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viraemia during Universal Test and Treat scale-up in Uganda: a population-based study.
Rosen JG; Ssekubugu R; Chang LW; Ssempijja V; Galiwango RM; Ssekasanvu J; Ndyanabo A; Kisakye A; Nakigozi G; Rucinski KB; Patel EU; Kennedy CE; Nalugoda F; Kigozi G; Ratmann O; Nelson LJ; Mills LA; Kabatesi D; Tobian AAR; Quinn TC; Kagaayi J; Reynolds SJ; Grabowski MK
J Int AIDS Soc; 2024 Feb; 27(2):e26200. PubMed ID: 38332519
[TBL] [Abstract][Full Text] [Related]
4. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viremia during Universal Test and Treat scale-up in Uganda: a population-based study.
Rosen JG; Ssekubugu R; Chang LW; Ssempijja V; Galiwango RM; Ssekasanvu J; Ndyanabo A; Kisakye A; Nakigozi G; Rucinski KB; Patel EU; Kennedy CE; Nalugoda F; Kigozi G; Ratmann O; Nelson LJ; Mills LA; Kabatesi D; Tobian AAR; Quinn TC; Kagaayi J; Reynolds SJ; Grabowski MK
medRxiv; 2023 Jun; ():. PubMed ID: 37398460
[TBL] [Abstract][Full Text] [Related]
5. Universal test and treat in Cameroon: a comparative retrospective analysis of mortality and loss to follow-up before and after a strategic change in approach to HIV care.
Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Yimdjo TD; Ateudjieu J; Kouanfack C; Djam A; Tabah EN; Whegang S; Mapa-Tassou C; Tendongfor N; Nsagha DS; Choukem SP
Pan Afr Med J; 2023; 45():191. PubMed ID: 38020352
[TBL] [Abstract][Full Text] [Related]
6. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
[TBL] [Abstract][Full Text] [Related]
7. Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya.
Kimanga DO; Oramisi VA; Hassan AS; Mugambi MK; Miruka FO; Muthoka KJ; Odhiambo JO; Yegon PK; Omoro GO; Mbaire C; Masamaro KM; Njogo SM; Barker JL; Ngugi CN
PLoS One; 2022; 17(11):e0277675. PubMed ID: 36413522
[TBL] [Abstract][Full Text] [Related]
8. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study.
Grabowski MK; Patel EU; Nakigozi G; Ssempijja V; Ssekubugu R; Ssekasanvu J; Ndyanabo A; Kigozi G; Nalugoda F; Gray RH; Kalibbala S; Serwadda DM; Laeyendecker O; Wawer MJ; Chang LW; Quinn TC; Kagaayi J; Tobian AAR; Reynolds SJ
J Infect Dis; 2021 Apr; 223(7):1150-1160. PubMed ID: 33471100
[TBL] [Abstract][Full Text] [Related]
10. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
[TBL] [Abstract][Full Text] [Related]
11. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
[TBL] [Abstract][Full Text] [Related]
12. HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa.
Hirasen K; Fox MP; Hendrickson CJ; Sineke T; Onoya D
Ther Clin Risk Manag; 2020; 16():169-180. PubMed ID: 32184609
[TBL] [Abstract][Full Text] [Related]
13. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
[TBL] [Abstract][Full Text] [Related]
14. HIV viral load suppression among people with mental disorders at two urban HIV clinics in Uganda: a parallel convergent mixed methods study using the social ecological model.
Ndagire R; Wangi RN; Ojiambo KO; Nangendo J; Nakku J; Muyinda H; Semitala FC
AIDS Res Ther; 2023 Sep; 20(1):68. PubMed ID: 37726822
[TBL] [Abstract][Full Text] [Related]
15. Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study.
Filiatreau LM; Edwards JK; Masilela N; Gómez-Olivé FX; Haberland N; Pence BW; Maselko J; Muessig KE; Kabudula CW; Dufour MK; Lippman SA; Kahn K; Pettifor A
BMC Public Health; 2023 Sep; 23(1):1724. PubMed ID: 37670262
[TBL] [Abstract][Full Text] [Related]
16. The effect of "universal test and treat" program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia.
Girum T; Yasin F; Wasie A; Shumbej T; Bekele F; Zeleke B
AIDS Res Ther; 2020 May; 17(1):19. PubMed ID: 32423457
[TBL] [Abstract][Full Text] [Related]
17. HIV viral load suppression among people with mental disorders at two urban HIV Clinics in Uganda: a parallel convergent mixed methods study using the Social Ecological Model.
Ndagire R; Wangi RN; Ojiambo KO; Nangendo J; Nakku J; Muyinda H; Semitala FC
Res Sq; 2023 May; ():. PubMed ID: 37214962
[No Abstract] [Full Text] [Related]
18. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
19. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
20. Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Brazier E; Tymejczyk O; Wools-Kaloustian K; Jiamsakul A; Torres MTL; Lee JS; Abuogi L; Khol V; Mejía Cordero F; Althoff KN; Law MG; Nash D;
PLoS Med; 2024 Mar; 21(3):e1004367. PubMed ID: 38498589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
